HaiBang Ventures

Developer of high-performance orthopedic implant and surgical technology systems. The company offers products including spine and artificial joint trauma systems, orthopedic data acquisition and processing systems, and 3D biomimetic additive manufacturing. The company's goal is to assist healthcare practitioners to strengthen and speed up medical services to patients.

Developer of machine vision technology and products, standardized light source modules, and related algorithms. The company's main products include high-reflective surface three-dimensional shape measuring instruments, LED chip packaging appearance inspection equipment, mobile phone glass cover appearance inspection equipment, mobile phone middle frame glue line inspection equipment, mobile phone middle frame flatness, straightness inspection equipment, injection molded parts Professional 3D measurement and appearance inspection equipment such as appearance inspection equipment, sheet metal online inspection equipment, and plastic parts appearance inspection equipment,more

Odianyun, officially known as Haiou Electric Cloud Information Technology Co., Ltd., is a prominent provider of cross-platform e-commerce cloud services and solutions. Established in March 2015, the company focuses on the research and development of large-scale e-commerce systems that encompass back-end supply chain management and e-commerce websites across various channels, including PC, mobile, and physical stores. Odianyun specializes in creating SaaS platforms that facilitate omni-channel e-commerce operations, enabling vendors to effectively manage their supply chains, retail services, and communications. The company's mission is to transform traditional businesses into modern, digitally-driven enterprises, aligning with the "Internet +" era. Recognized as a leader in e-commerce innovation, Odianyun emphasizes delivering high-quality products and services while fostering a culture centered on social value and operational excellence.

T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. T-Maximum's gene-editing allogeneic immune cell therapy adopts the version 3.0 program with completely independent intellectual property rights to realize allogeneic universal CAR-T therapy and solve the risk of graft-versus-host disease and rejection of allogeneic immune cells.

Realmind Biotech specializes in the development and manufacturing of in vitro diagnostic (IVD) devices aimed at enhancing medical assessments. The company's innovative product line includes a range of diagnostic equipment such as miniaturized chemiluminescence analyzers, fully automated chemiluminescence point-of-care testing (POCT) systems, and microdroplet chip POCT technologies. These devices are utilized for various applications, including tumor detection and hormone testing, enabling real-time diagnosis. Realmind Biotech also provides specialized reagents to support healthcare professionals and patients in their diagnostic needs. Through its comprehensive blueprint of advanced IVD platforms, the company aims to improve the accuracy and efficiency of medical assessments.

TYK Medicines, Inc. operates as a biotechnology company. It focuses on the research and development of anti-cancer drugs. The company was founded in 2017 and is based in Shanghai, China.

Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company specializing in the development and sale of protein and peptide drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company focuses on therapeutic areas such as diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neuro-degenerative conditions. Sciwind's innovative drug candidates are particularly targeted at metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for healthcare professionals and their patients.

Hangzhou Joinhealth Technology Co., Ltd. specializes in developing software solutions for medical follow-up and post-hospital management. Founded in 2015 and headquartered in Hangzhou, China, the company offers a range of products including systems for hospital follow-up, VIP customer management, chronic disease management, and maternal and child health. Joinhealth Technology integrates artificial intelligence and advanced technologies like the Internet and Internet of Things to enhance patient management. By shifting the focus from disease treatment to comprehensive disease management, the company facilitates intelligent management of patients throughout their healthcare journey, from hospital care to home and potential re-admission.

壹点灵 is a psychological counselor platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

Operator of a platform that provides automated document translation services. The company uses artificial intelligence and big data to help provide their clients with the most accurate document translations in nearly 100 different languages.

Hangzhou Realy Tech Co., Ltd. specializes in the research, manufacture, and sale of point-of-care testing (POCT) kits and equipment. Founded in 2015 and located in Hangzhou, China, the company develops at-home diagnostic devices that deliver rapid medical testing results. Their product range includes immunoassays designed to detect various health indicators, such as cardiac markers, thrombosis, inflammation, kidney function, and fertility. By providing immediate diagnostic information, Realy's products enable patients to make informed health decisions quickly.

Developer of high-performance orthopedic implant and surgical technology systems. The company offers products including spine and artificial joint trauma systems, orthopedic data acquisition and processing systems, and 3D biomimetic additive manufacturing. The company's goal is to assist healthcare practitioners to strengthen and speed up medical services to patients.

IMPACT Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing therapeutics for cancer and other serious diseases. Founded in 2009 and headquartered in Shanghai, China, the company is engaged in several research and development projects, including the development of PARP inhibitors, Wee1 inhibitors, novel DNA damage response agents, and Hedgehog pathway inhibitors. IMPACT Therapeutics aims to create best-in-class drugs with independent intellectual property rights, emphasizing the discovery of targeted anti-cancer therapies based on the principle of synthetic lethality. The company’s management team possesses extensive experience in drug development and management, with a strong background in pharmacology and biology, which supports its mission to provide innovative treatments for patients with life-threatening conditions.

Hangzhou Realy Tech Co., Ltd. specializes in the research, manufacture, and sale of point-of-care testing (POCT) kits and equipment. Founded in 2015 and located in Hangzhou, China, the company develops at-home diagnostic devices that deliver rapid medical testing results. Their product range includes immunoassays designed to detect various health indicators, such as cardiac markers, thrombosis, inflammation, kidney function, and fertility. By providing immediate diagnostic information, Realy's products enable patients to make informed health decisions quickly.

Developer of public security emergency platform designed to provide solutions for public security industry. The company is engaged in R&D, production, sales and related services of public security emergency platform software and hardware. The company's service areas cover urban emergency, urban lifeline monitoring project, earthquake disaster mitigation, public health, grassroots governance, intelligent human defense, intelligent mine and intelligent park.

Zylox Medical Device Co. was founded in the beautiful city of Hangzhou in 2012 by a group of highly skillful and experienced returnees from the US and Europe. They have on average 5-20 years of working experiences in various functional areas such as research and development, management, and manufacturing in leading device makers including Johnson & Johnson, Medtronic, and Abbott before returning to China. Since its inception, Zylox has developed an increasingly rich product pipeline of interventional and implantable peripheral vascular devices such as PTA balloons, PTA drug-coated Balloons (PTA DCB), superficial femoral artery (SFA) stent, drug-eluting SFA stent, and other vascular accessories. Zylox strives to continuously innovate and provide patients with superior quality medical devices.

Provider of video communication cloud technology services designed to focus on independent research and development. The company's collaborative video conference devices offer video conferencing with an integrated terminal, audio and video PaaS platform, and SaaS cloud service, enabling users to avail of data sharing that supports conference and training.

Zhejiang InnoTek Co., Ltd. is engaged in the development of wireless sensor technology products tailored for Internet-of-Things applications and personal positioning services. The company specializes in smart parking management and guidance systems, judicial community correction systems, and integrated personal positioning monitoring systems. Its offerings are utilized across various sectors, including smart traffic management and smart judicature. InnoTek's software solutions encompass parking information collection, unified charging management, and intelligent toll terminal charging management, which facilitate efficient parking management for car park owners and policymakers. Established in 2011 and headquartered in Hangzhou, China, InnoTek collaborates strategically with prominent telecommunications companies to enhance its technology and service offerings.

Zannan SciTech Co., Ltd. operates as a pharmaceutical contract research organization and polymer development company. It offers products and technology services, such as Zhan (Ru) catalysts for metathesis reactions; BNBR rubbers; building blocks and API intermediates; custom synthesis, FTE research, and process research and development (PDS) services; and contract manufacturing services. The company also provides hydrogenated nitrile butadiene rubber; HCV inhibitors; and polydicyclopentadiene, a polymer that is used as a plastic material in car, pipe, and building materials. Zannan SciTech Co., Ltd. was formerly known as Zannan Pharma Ltd. and changed its name to Zannan SciTech Co., Ltd. in December, 2009. The company was founded in 2003 and is based in Shanghai, China.